Dr. Reddy's Laboratories Limited, Manufacturing Unit - 9

The drug is indicated for the treatment of postmenopausal women with locally advanced or metastatic breast cancer that is estrogen receptor-positive. It is used both as monotherapy and in combination with palbociclib.

Dosage form: solution for injection

ATC: L02BA03